Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 265

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 265
---
 |     |             |   |     |               |            |     |          |      |     |            |           |
|                 |     | Option              
 Grant Date          |           |     | Vesting      
 Commencement 
 Date         |           |     | Number of   
 Securities  
 Underlying  
 Unexercised 
 Options (#) 
 Exercisable |   |     | Number of     
 Securities    
 Underlying    
 Unexercised   
 Options (#)   
 Unexercisable |            |     | Option   
 Exercise 
 Price    
 ($)      |      |     | Option     
 Expiration 
 Date       |           |
| Jaisim Shah     |     |                     | 8/30/2024 |     |              | 8/30/2024 |     |             | — |     |               | 21,875,000 |     |          | 1.27 |     |            | 8/30/2034 |
| Henry Ji, Ph.D. |     |                     | 8/30/2024 |     |              | 8/30/2024 |     |             | — |     |               | 21,875,000 |     |          | 1.27 |     |            | 8/30/2034 |
| Stephen Ma      |     |                     | 8/30/2024 |     |              | 8/30/2024 |     |             | — |     |               |  2,500,000 |     |          | 1.27 |     |            | 8/30/2034 |

**(1) Each option was granted under the 2024 Stock Option Plan. The number of shares underlying each option and the exercise price set forth in this table reflect the application of the Exchange Ratio in the Business Combination. 172

(2) 1/48th of the total amount of the shares vested and shall vest each month after the Option Grant Date, subject to the executive officer’s providing continuous service (as defined in the 2024 Stock Option Plan) on each such vesting date, inclusive.

Equity-Based Incentive Plan

Semnur Pharmaceuticals, Inc. 2024 Stock Option Plan

The Board adopted the 2024 Stock Option Plan on August 30, 2024. The 2024 Stock Option Plan was approved by Semnur’s then sole stockholder on August 30, 2024. Upon adoption, 40